New Report Finds Information Technology Essential But Not Sufficient in Long... (leadership of executive director Doug Pa...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

New Report Finds Information Technology Essential But Not Sufficient in Long-Term Care

Date:10/4/2007

leadership of executive director Doug Pace. For more information, visit the Commission's Web Site at http://www.ncqltc.org.

National Commission for Quality Long-Term Care Commissioners

The Honorable Newt Gingrich (Co-Chair)

CEO, The Gingrich Group

The Honorable Bob Kerrey (Co-Chair)

President, The New School

The Honorable Haley Barbour

Governor of Mississippi

The Honorable Phil Bredesen

Governor of Tennessee

The Honorable David Durenberger

Chair, National Institute of Health Policy

Former Senator from Minnesota

Monsignor Charles J. Fahey

Fordham University

The Honorable Nancy L. Johnson

Former Congresswoman from Connecticut

Mary Jane Koren, MD

Assistant Vice President, The Commonwealth Fund

Mike Magee, MD

Senior Fellow in Health Policy, CAST; Host, HealthCommentary.org; Co-

Director, Rocking

Chair Project

The Honorable Jim McCrery

Congressman from Louisiana

Michael Millenson

Independent consultant and the Mervin Shalowitz, MD Visiting Scholar,

Health Industry

Management Program, Kellogg School of Management

William D. Novelli

CEO, AARP

Richard Payne, MD

Director, Duke Institute on Care at the End of Life, Duke University

Divinity School

The Honorable Earl Pomeroy

Congressman from North Dakota

Sister Mary Jean Ryan

President and CEO, SSM Health Care

Judith A. Salerno, MD, MS

Deputy Director, National Institute on Aging, National Institutes of

Health (NIH)

William J. Scanlon

Consultant

The Honorable Gordon Smith

Senator from Oregon

Sandra R. Smoley, RN, BSN

President and CEO, The Sandy Smoley Group

Buck Stinson

President, Long-Term Care Insurance, Genworth Financial

Jeanette C. Takamura, MSW, PhD

Columb
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. No harm in reducing prenatal check up to 3 - 6 times says WHO report
2. Autopsy reports could be valuable and informative
3. China reports declining number of SARS Cases
4. Russia Reports First SARS Case
5. Report on the Safety and Effectiveness of Melatonin supplements
6. WHO report asks for improved healthcare for mother and child
7. Research reports that c-section deliveries are rising
8. Jharkhand reports 13,000 Malaria cases
9. Sepsis Death Reported With Mifepristone – FDA Issues Warnin
10. Experts Insist That Neonatal Herpes Be Reported Regularly
11. Uganda Reports Failure To Contain Sleeping Sickness

Post Your Comments:

Breaking Medicine News(10 mins):Health News:Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting 2 Health News:Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health 2 Health News:Molecule Discovery Might Help ALS Patients 2 Health News:Swine Flu Has Infected 1 in 6 Americans: CDC 2 Health News:Swine Flu Has Infected 1 in 6 Americans: CDC 3 Health News:Macomb County Announces New Location for Four Upcoming H1N1 Clinics 2

[1] Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting [0] Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health [0] Molecule Discovery Might Help ALS Patients [0] Swine Flu Has Infected 1 in 6 Americans: CDC [0] Macomb County Announces New Location for Four Upcoming H1N1 Clinics

Priligy(TM) (Dapoxetine) Receives First Regulatory Approvals for the Treatment of Premature Ejaculation (PE) in Finland and Sweden Garry W. Rogerson Elected Chairman of the Board of Varian, Inc.Smokers Will Stop for Their Pet's Sake Diseased Heart Valve Replaced Through Small Chest Incision The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders Shaklee Hits the Road with its Infinite Possibilities Tour in New York, NY

Breaking Medicine Technology:ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2 ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3 ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4 Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2 Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3 Within3 Expands into Mobile Applications 2 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 1 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 2 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 3 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 4 Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Associat 12518 5 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 1 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 2 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 3 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 4 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 5 Angiotech Pharmaceuticals announces FDA 510 28k 29 clearance of the Option 28TM 29 Inferior Vena Cava Filter 12515 6 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 1 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 2 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 3 Industry Professionals Get Schooled in Real World Oncology Issues at NCCN Academy 12512 4

[0] ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)[0] Boston Scientific Announces Pricing of $2 Billion of Senior Notes [0] Within3 Expands into Mobile Applications

Other Medicine Technology:Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 2 Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 3 Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis 2

Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis

Medicine Products:

Hydrophobic Tubing Filter (green-tinted PVC)Clear-Therm Mini™ + Micro Mount with Flextube Clear-Therm®Filta-Therm® with CO₂ Port

New Report Finds Information Technology Essential But Not Sufficient in Long...(leadership of executive director Doug Pa...),Health